- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03550937
Hospital-based Surveillance of Rotavirus Gastroenteritis in Young Taiwanese Children
June 15, 2018 updated by: National Taiwan University Hospital
Hospital-based Surveillance of Severe Rotavirus Gastroenteritis and Diversity of Circulating Rotavirus Strains in Young Taiwanese Children
Rotavirus remains among the leading causes of pediatric gastroenteritis requiring hospitalization in the world.
Surveillance studies revealed that more than 90% of the global circulating rotavirus strains were predominated by several major genotypes.
Clinical trials and post-marketing studies have demonstrated that the currently available rotavirus vaccine can provide sufficient protection against strains of the prevalent genotypes.
However, the emerging strains with new genotypes were increasingly reported in the past decade, an ongoing surveillance of the strain changes is needed in the regions where the pediatric population is either fully or partly immunized.
In this project, the investigators will setup a hospital-based gastroenteritis surveillance network by incorporating 8 major hospitals in northern, central, southern and eastern Taiwan.
From 2013 to 2015, children aged 5 years or younger hospitalized to one of the 8 sentinel hospitals due to acute gastroenteritis will be screened for rotavirus infection, and viral proteins 7 [VP7] (G type) and viral proteins 4 [VP4] (P type) genotypes of rotavirus will be determined for each infected case.
The demographics and clinical manifestations of study subjects will also be collected and analyzed.
Through this project, the investigators will be able to detect emerging genotypes of rotavirus and delineate the strain distribution during the two years of study in Taiwan.
The investigators can also have more comprehensive understanding of the epidemiology of rotavirus regarding to the incidence, disease characteristics, temporal and geographic variations of severe rotavirus gastroenteritis in Taiwanese children.
Results from this project will provide valuable information for future implementation of mass immunization against rotavirus in Taiwan.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
5040
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Chang Hua, Taiwan
- Chang Bing Show Chwan Memorial Hospital
-
Chang Hua, Taiwan
- Chang Hua Show Chwan Memorial Hospital
-
Douliu, Taiwan
- National Taiwan University Hospital Yun-Lin Branch
-
Hualien City, Taiwan
- Buddhist Tzu Chi General Hospital, Hualien Tzu Chi Medical Center
-
Kaohsiung, Taiwan
- Kaohsiung Chang Gung Memorial Hospital
-
Taichung, Taiwan
- China Medical University Hospital
-
Tainan, Taiwan
- National Cheng Kung University Hospital
-
Taipei, Taiwan
- Mackay Memorial Hospital
-
Taipei, Taiwan
- National Taiwan University Hospital
-
Taoyuan, Taiwan
- Chang Gung Children's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 5 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Hospitalized children having diarrhea and less than 60 months of age
Description
Inclusion Criteria:
- aged less than 60 months,
- hospitalized in 1 of the 8 hospitals,
- having diarrhea not caused by any known underlying diseases.
Exclusion Criteria:
- No
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
monitor the strain diversity of rotavirus in Taiwan
Time Frame: 4 years
|
monitor the strain diversity of rotavirus in Taiwan, including the individual serotype prevalence and emerging genotypes
|
4 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 11, 2013
Primary Completion (Actual)
February 6, 2018
Study Completion (Actual)
February 6, 2018
Study Registration Dates
First Submitted
May 28, 2018
First Submitted That Met QC Criteria
May 28, 2018
First Posted (Actual)
June 8, 2018
Study Record Updates
Last Update Posted (Actual)
June 18, 2018
Last Update Submitted That Met QC Criteria
June 15, 2018
Last Verified
May 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201310064RINA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.